News Archive of Inside Industry - Gen

ArticleAdded
McKesson's $8.3B Celesio Deal Builds Drug Warehousing Powerhouse10-24-13
DSM, Sanquin Make Factor IX-Recovering mAb Manufacturing Deal10-24-13
Startup Wins Five-Year Exclusive License to deCODE Genetics Platform10-23-13
Cleveland BioLabs Subsidiary Awarded $4.6M Russian Contract10-23-13
Imugene Acquiring Biolife, as Lead Pipeline Candidate Nears Phase II10-23-13
PDL BioPharma Acquires Diabetes Royalty, Milestone Rights for $240.5M10-22-13
Novozymes, Almac Ally to Offer Drug Targeting, Pharmacokinetics Service10-22-13
Amgen Buys Roche Rights to Neutropenia Drugs10-22-13
Orygen to Manufacture Epirus' Remicade Biosimilar in Brazil10-22-13
MedMira Wins Additional $1.9M Army Contract10-21-13
Claritas Partners with Life Tech, Lockheed to Sequence Military Veteran Exomes10-21-13
U.K. Organizations Partner with Illumina to Sequence 10,000 Whole Genomes10-21-13
AstraZeneca, Evotec Launch Kidney Disease Collaboration10-21-13
CIRM President Steps Down after Six Years10-18-13
Genalyte Gets Grant from NCI to Develop Biomarker Panel for Cancer10-18-13
Ariad Ends Phase III Leukemia Drug Trial10-18-13
AstraZeneca, Taiwan's NRPB Launch Drug Discovery Collaboration10-17-13
Stem Cell Therapeutics Nabs SIRPa Protein-Targeting mABs10-17-13
Biotech CEO Faces Felony Charge of Computer Trespass10-16-13
Imaxio Sells Genomics Division to Hybrigenics10-16-13
CEO Faces Felony Charge of Computer Trespass10-16-13
Pieris Inks Co-Development Alliance with Zydus for Protein Drugs10-16-13
Sartorius and BD Sign Microbiological Diagnostics Deal10-16-13
Sartorius and BD Diagnostics Sign Microbiological Diagnostics Deal10-16-13
AstraZeneca to Use Wyss Institute's Organs-on-Chips10-16-13
CEL-SCI, Ergomed to Co-Develop Head and Neck Cancer Candidate as Potential HPV Treatment10-15-13
CEL-SCI, Ergomed to Co-Develop Head and Neck Cancer Candidate as Potential HPV Treatment10-15-13
Yale Launches Collaboration with ARO, CRO Partners10-11-13
Novartis Inks Agreement for ImmunoGen's "TAP" ADC Technology10-11-13
AstraZeneca, Janssen to Promote Novel Prostate Cancer Treatment in Japan10-11-13
Auxilium Licenses Stendra from Vivus for Up to $300M10-11-13
Yale Launches Collaboration with ARO, CRO Partners10-11-13
Novartis Inks Agreement for ImmunoGen's "TAP" ADC Technology10-11-13
AstraZeneca, Janssen to Promote Novel Prostate Cancer Treatment in Japan10-11-13
Auxilium Licenses Stendra from Vivus for Up to $300M10-11-13
Teva Cutting 5,000 Jobs in Global Restructuring10-10-13
Vivaldi Buys Flu Vaccine R&D Assets from Baxter10-10-13
J&J Innovation, Janssen, and Joslin Diabetes to Pump Up Exercise-Related Targets10-10-13
Catalyst, Isu Abxis to Develop Hemophilia B Candidate10-09-13
U.S. Research Will "Pay Dearly" for Shutdown, ASCB Warns10-09-13
Active Biotech and Hutchison China MediTech Get Rewarded10-09-13
Forma Achieves First Milestone in Celgene Collaboration10-08-13
Clinical Genomics Nabs Enterix, Aims to Launch New Bowel Cancer Blood Test10-08-13
J&J's Janssen Buys Rights to Hepatitis C Compound from GSK10-08-13
Sartorius to Acquire TAP Biosystems10-07-13
Eddingpharm Secures Immutep's ImmuFact IMP321 for Growing Stable10-07-13
A*STAR, Debiopharm Team Up to Develop Epigenetic Cancer Target10-07-13
Designer Baby Patent Awarded to 23andMe10-04-13
Merck Canada Awards $15.5M to Four Universities10-04-13
Eppendorf Sponsoring Shared Lab Space at Cambridge, MA10-04-13
Lilly Peers Into Future, Sees Three Drug Launches in 201410-03-13
X-Chem, AstraZeneca Expand Drug Discovery Collab10-03-13
J&J's Janssen Companies Launch a Trio of Collaborations10-03-13
AAIPharma Merges with Cambridge Major Laboratories10-02-13
Moderna Therapeutics Scores Up to $25M DARPA Grant10-02-13
Servier Joins Xention to Develop AF Drug in Up to $163.2M Deal10-02-13
Acino Supports Acquisition by Private Equity Firms10-02-13
Sofie Bio Seeks to Speed PET Probe Synthesis with SBIR Grant10-02-13
Lundbeck Cutting 180-200 Jobs in Business Services Overhaul10-01-13
FDA Approves Takeda-Lundbeck Drug for Major Depressive Disorder10-01-13
Merck & Co. Axes 8,500 in R&D Restructuring10-01-13
WATCH: The Novex Bolt Orchestra10-01-13
Lundbeck Cutting 180-200 Jobs in Business Services Overhaul10-01-13
FDA Approves Takeda-Lundbeck Drug for Major Depressive Disorder10-01-13
Merck & Co. Axes 8,500 in R&D Restructuring10-01-13
Pfizer Licenses Gliknik's GL-2045 in $25M+ Deal09-30-13
Pfizer Licenses Gliknik's Pooled IVIG in $25M+ Deal09-30-13
Merck Canada Gives Patient-Oriented Research $4M Boost09-30-13
GSK Sells Thrombosis Brands to Aspen for $1.13B09-30-13
Malvern Instruments Acquires NanoSight09-30-13
Ablynx Nets Another $33.7M from Merck Serono as Partnership Expands09-26-13
Regado Axes 15% of Staff, Focuses on Phase III Trial09-27-13
Allergan Licenses Rights to Medytox Candidates, in Up-to-$362M Deal09-26-13
Biosearch Technologies Acquires Majority Stake in LightSpeed Genomics09-25-13
Roche, Pac Bio in Up to $75M Clinical Diagnostics Deal09-25-13
Global Genomics Group Enlists Illumina for Cardiovascular Disease Study09-25-13
NCI Re-Ups BioMarker Strategies? SBIR Award for Melanoma CDx09-25-13
Amgen Plans R&D Center in China09-25-13
Federal Data Shows R&D Spending Slide09-25-13
Pancreatic Cancer Imaging Agent Earns MabVax $1.75M SBIR Award09-24-13
AstraZeneca Licenses 3 X-Chem Drug Discovery Programs09-24-13
NCI Funds Development of Chrysalis? Brain Tissue Damage Treatment09-24-13
AbbVie, Galapagos Ink Up to $405M CF Collaboration09-24-13
AbbVie, Ablynx Ink Up to $840M RA, SLE Collaboration09-23-13
BASF Eyes Strategic Protein Growth, Buys Verenium for $62M09-20-13
Sanofi Opens Cancer Research Hub in Cambridge, MA09-20-13
NY Genome Center Marks Its Formal Launch09-19-13
OrbeShield Earns Soligenix Up to $26.3M from BARDA09-19-13
Agilent Marries Life-Sci and Diagnostics, on Eve of Measurement Spinout09-19-13
Google Eyes Wider Healthcare Footprint with Tech-Focused Calico09-19-13
GSK Returns Vercirnon Rights to ChemoCentryx after Phase III Flop09-18-13
BARDA Exercises $6M Option for Aeolus' Acute Radiation Syndrome Drug09-18-13
Dendreon Gets Green Light in Europe09-17-13
Genzyme's MS Drug Lemtrada Receives EU Authorization09-17-13
BioCryst Wins Potentially $22M NIAID Contract to Develop Marburg Virus Disease Drug09-17-13
BMS Licenses PeptiDream Technology, Extends Collaboration09-17-13
Sigma-Tau PharmaSource, Aradigm Ink Manufacturing Deal for Respiratory Disease Treatment09-16-13
NeoStem Licenses UCSF Patents Covering Methods for "Tregs"09-16-13
Bruker Launches Second Phase of SISCAPA-MALDI Collaboration09-16-13
Bruker Nabs Prairie, Bolstering Its AFM Line09-13-13
MJFF Forms Research Tool Development Consortium for Parkinson's09-13-13
Columbia Labs Buys Molecular Profiles for $25M09-12-13
Harvard Stem Cell Institute, Evotec Team Up to Take on ALS09-12-13
Innovus Wins License to Market Sexual Dysfunction Drug in Morocco09-11-13
HedgePath, Mayne Repurposing Fungal Infection Drug for Cancer09-11-13
AstraZeneca Licenses Merck's Cancer Candidate MK-177509-11-13
Bayer, Broad on Five-Year Mission to Search for Novel Cancer Therapeutics09-10-13
AstraZeneca, Hadasit Launch Drug Discovery Alliance09-10-13
Rhythm Awarded $1.35M from Michael J. Fox Foundation09-10-13
Biogen Idec, Amicus Launch Parkinson's Collaboration09-10-13
Roche Signs Up to $422.5M Collaboration with Inovio09-10-13
Cellceutix Scoops Up Bankrupt PolyMedix09-09-13
Oncodesign, Banook Central Imaging to Develop Cancer Biomarkers09-09-13
Biogen Idec and Isis Ink Fourth Deal in Two Years09-09-13
NIH Funds Minority Disease Susceptibility Studies09-06-13
Enzymatics Acquires ArcherDx for Up to $50M09-06-13
Sanofi to Commercialize Pozen Proton Pump Inhibitor/Aspirin Product09-05-13
Capsugel Nabs Bend Research09-05-13
Rigel Cuts 30 Jobs, Refocuses on Three Clinical Programs09-05-13
Otsuka Acquires Astex for $866M09-05-13
Ultragenyx, Kyowa Hakko Kirin to Develop Rare Bone Disease-Fighting mAb09-04-13
Revived GenVec Withdraws Dissolution Plan; New CEO Named09-04-13
Repligen Earns $1M Pfizer Milestone Payment09-04-13
Accelrys Buys ChemSW in Deal Worth Up to $17.3M09-04-13
Taconic to Promote and Sell Medicyte Hepatocyte Products09-04-13
Baxter, Coherus Ink Biosimilar Collaboration Worth Up to $246M09-03-13
Enanta Gets Additional $9.2M toward Biodefense Antibiotic Development09-03-13
Cangene Signs up to $77M Contract Extension with CDC09-03-13
Cangene Inks up to $77M Contract Extension with CDC09-03-13
Endo Eyes Generics Growth with $225M Boca Pharmacal Acquisition08-28-13
Teva Declines Right to License Rexahn Cancer Drug08-28-13
University of Virginia Gets $14.4M Grant to Fight Hypertrophic Cardiomyopathy08-27-13
Haplogen, CeMM Offer Huge Collection of Mutant Cell Lines08-26-13
Thermo Acquisition Gets Thumbs Up from Life Tech Stockholders08-22-13
Takeda Launches New Subsidiary in Peru08-22-13
PsychoGenics Picks Up Alzheimer's Animal Model from USF08-21-13
Evotec and Jain Extend Research Collab in Skeletal Muscular Dystrophy08-21-13
GeneNews Axes 60% of Staff to Boost New JV08-20-13
Adimab Scores Two Deals and Some Milestone Payments08-20-13
PDI Expands Focus with MDx Commercialization Deal08-20-13
SeraCare Nabs KPL08-19-13
GSK Wins FDA Approval for FluLaval Quadrivalent08-16-13
Lilly-Boehringer Diabetes Drug Shows Promise in Phase III08-16-13
Genalyte Launches Type 1 Diabetes Antigen Panel, BDC Collaboration08-15-13
Seattle BioMed Wins $16.6M Grant to Tackle Tuberculosis08-15-13
Amunix, Janssen Expand XTEN Collaboration08-14-13
Quintiles Acquires Novella Clinical08-14-13
Ligand, CURx Make $21M Injectable Epilepsy Drug Deal08-14-13
Myelin Repair Foundation, Gencia Partner to Speed Up MS Drug Development08-14-13
Sunovion, Afraxis to Use ESP to Discover New CNS Compounds08-13-13
FDA Approves Viiv Healthcare's HIV-1 Treatment Tivicay08-13-13
Pfizer, Sanford-Burnham Team Up on Obesity, Diabetes Target Research08-13-13
Lilly Phase III Candidate Meets Primary Endpoint of NSCLC Overall Survival08-13-13
Endo Unit Sells HealthTronics Laboratory Solutions to Metamark Genetics08-13-13
Endo Unit Sells HLS to Metamark Genetics08-13-13
Teva, Perrigo to Launch Generic Temodar08-12-13
Epistem Wins Grant to Develop Point-of-Care HepC Tests08-12-13
Vical Scraps Melanoma Candidate After Phase III Failure08-12-13
Department of Defense Forges New Alliances in War against Prostate Cancer08-09-13
Breckenridge Buys ANDAs for $30M from Pernix' Cypress Unit08-09-13
Roche Pays PTC $10M in Spinal Muscular Atrophy Collaboration08-08-13
Luminex Cuts Jobs, Closes Australia Office08-08-13
MultiCell, Genisphere to Target Liver Cancer with Nanoparticles08-06-13
Athersys Gets Up to $2.8M for Heart Attack Regen Med Program08-06-13
Novartis, Ensemble Therapeutics Launch Collaborations08-06-13
Pluristem Wins $3.3M Israeli Grant to Advance Pipeline08-06-13
Life Tech, RainTree Launch Oncology Testing, Patient Data Initiatives08-05-13
New England Biolabs Gains Access to Advanced NGS Library Prep Method08-05-13
Bayer Collaboration Could Net $540M+ for Compugen08-05-13
Beckman Coulter Life Sciences Acquires ReaMetrix' Flow Cytometry Business08-02-13
Double Manufacturing Deals for Sanofi08-01-13
AstraZeneca to Co-Develop FibroGen Anemia Compound in Up to $815M Deal07-31-13
Stratatech Wins Up to $47.2M BARDA Grant to Advance Skin Tissue Engineering07-31-13
Merck, Bionomics Make Potentially $172M Pact to Search for Chronic Pain Treatments07-31-13
Cubist Acquires Two Antibiotics Developers in Deals Totaling $1.6B+07-31-13
Isis Wins $2M Milestone Payment from GSK for Antisense Drug Candidate07-30-13
ReGenX, Audentes Team Up to Develop Rare Muscle Disease Treatments07-30-13
Servier to Develop Nerviano Anticancer Compounds in Up to $143.6M Deal07-30-13
Crown Bioscience Acquires U.K. CRO Precos07-30-13
Celgene Raises Acetylon Stake with Option to Buy for Potentially $1.6B+07-29-13
Celgene Raises Acetylon Stake with Option to Buy for Up to $1.1B07-29-13
Samsung Biologics, BMS in Manufacturing Partnership07-29-13
Pfizer Splitting Commercial Operations Three Ways, Inks Supply Agreement with UNICEF07-29-13
Perrigo Buying Elan for $8.6B07-29-13
PolyTherics Expands Drug Development Services with Antitope Purchase07-26-13
Recordati Eyes Growth with Opalia Pharma Acquisition07-25-13
Oxford Pharmascience Wins Option for 53 More UCL Compounds07-25-13
Biosimilar Marriage Ends in Divorce for Teva, Lonza07-25-13
EFPIA, PhRMA: Trial Data-Sharing Benefits Patients, Scientists, and Public07-25-13
Genentech Trumpets Phase III Results for CLL Candidate07-24-13
Transition Scores Rights to Develop Lilly Osteoarthritis Pain Drug07-24-13
Ligand Inks Week's Second Lasofoxifene Licensing Deal07-24-13
Illumina Acquires Microfluidics Firm Advanced Liquid Logic07-23-13
Consortium to Study Alzheimer's Drug Candidate with $11.3M Bpifrance Grant07-23-13
AD Biotech, Quest to Codevelop Cancer-Fighting Immunotherapeutics07-23-13
Galapagos Wins $4M Milestone Payment in Servier Osteoarthritis Alliance07-23-13
NIAID Grants MBio $1.4M to Develop POC HIV Diagnostic07-22-13
Azure Nabs Rights to Ligand Lasofoxifene Formulation07-22-13
Biogen Idec, University of Edinburgh Team Up for Neurodegenerative Disease R&D07-19-13
Royalty Pharma Buys Quest Cancer Candidate Royalty Rights for $485M07-18-13
Mesoblast Wins $3.9M in Australian Tax Credits Tied to Mesenchymal Precursor Cells07-18-13
Sigma-Aldrich Partners with Scripps in Reagents R&D07-18-13
Mesoblast Wins $3.9M in Australian Tax Credits Tied to Mesenchymal Precursor Cells07-18-13
Sigma-Aldrich Partners with Scripps in Reagents R&D07-18-13
Ultra-Rare Disorders Targeted in Ensemble, Alexion Collab07-18-13
Ultra-Rare Disorders Targeted in Ensemble, Alexion Collab07-18-13
Pfizer Licenses Phase II TB Antibiotic Rights to Sequella07-17-13
M&A Doubleheader: Two Ailing Companies Bought Out07-17-13
Rexahn Licenses University of Maryland Cancer Drug Delivery Platform07-17-13
MDxHealth, HistoGeneX Team Up on MDx Services07-16-13
Immobilized Enzymes Focus of Purolite, Codexis Partnership07-16-13
Life Tech Gets Deeper into Dx Business with Merck Collaboration07-16-13
ADC, BZL Aim Warheads at PSMA-Positive Prostate Cancers07-15-13
Ipsen to Acquire Syntaxin for $206M+07-15-13
FDA Gives Nod to Boehringer NSCLC Drug, Qiagen CDx07-12-13
C2N, Cambridge Isotope Laboratories Pair Up for Alzheimer's Biomarkers07-12-13
Mitsubishi Tanabe Buys Medicago for $357M07-12-13
Celgene Drug Shows Phase III Promise for Newly Diagnosed Multiple Myeloma07-11-13
AB Sciex, Beckman Coulter Combining Chromatography, CE Businesses07-11-13
Serodus Acquires Phlogo, Grows Pipeline with Preclinical Peptides07-10-13
Roche Halts Type 2 Diabetes Candidate Trial After Phase III Failure07-10-13
GSK Partners with Immunocore in Potentially $508M+ ImmTACs Deal07-09-13
AstraZeneca Launches Cancer Collaborations07-09-13
Pact Builds Amgen Cardiovascular Drug Presence, Could Net Servier $50M+07-09-13
Up to $12M Deal Expands Acorda Offerings to Neuropathic Pain07-09-13
Leica Biosystems Nabs Kreatech07-08-13
Evotec Scores $1.9M Boehringer Milestone Payday07-08-13
Public Health England to Test Nanoviricides Against H7N9, MERS07-08-13
Nile Therapeutics to Acquire Capricor07-08-13
Pink Slips for 120 in Evotec R&D Restructuring Move07-08-13
Roche Buys CMI, Creates Hematology Dx Hub In $220M+ Deal07-03-13
VWR Buys United Biochemicals07-02-13
Ovarian Cancer Treatment Milestone Earns Array BioPharma $5M07-02-13
Xencor Licenses MAb Patent to Merck & Co.07-02-13
Protagen Sells Protein Services Business to German VC Firm07-02-13
Protagen Sells Protein Services Business to German VC Firm07-02-13
Most Responders to GEN Poll Would Consider Relocating for Work07-01-13
Biogen Idec, Myelin Repair Foundation Eye New Mouse Model Against MS07-01-13
Onyx Spurns Amgen Offer, Pursues Its Own Deal07-01-13
AmpliPhi Joins U.S. Army to Battle Bacterial Infections07-01-13
Most Responders to GEN Poll Would Consider Relocating for Work07-01-13
Biogen Idec, Myelin Repair Foundation Eye New Mouse Model Against MS07-01-13
Onyx Spurns Amgen Offer, Pursues its Own Deal07-01-13
AmpliPhi Joins U.S. Army to Battle Bacterial Infections07-01-13
AstraZeneca, Karolinska Institutet to Launch $100M Cardiovascular, Metabolic Disease Center07-01-13
Genewiz Collaboration Spree Covers Ovarian Cancer Biomarkers, Next-Gen MDx06-28-13
Neopharm Group Scoops Up Fresenius Biotech06-28-13
Abandoned Inventions Find New Home with Marblar Contests06-28-13
New Indiana Institute Wins $10M from Lilly Endowment06-27-13
Genentech Makes Potentially $300M+ Pact for Immunocore's ImmTACs06-27-13
Celgene, MorphoSys Ink Up to $818M Deal to Move Multiple Myeloma Drug Forward06-27-13
In $1B Deal, Merck Sells API Business, 11-Drug Portfolio06-27-13
J&J Opens Boston Innovation Center, Strikes Additional Early-Stage Deals06-27-13
J&J Opens Boston Innovation Center, Strikes Additional Early-Stage Deals06-27-13
Kiadis Pharma Wins $3.9M Loan to Develop Blood Cancer Treatment06-26-13
MD Anderson to Test Cellceutix Candidate Against Lymphoma, Multiple Myeloma06-26-13
Roche, AstraZeneca to Share Some Drug Design Data06-26-13
NCATS Eyes Changes to CTSA as Sequestration Limits Options06-25-13
Kiadis Pharma Wins $3.9M Loan to Develop Blood Cancer Treatment06-26-13
MD Anderson to Test Cellceutix Candidate Against Lymphoma, Multiple Myeloma06-26-13
Roche, AstraZeneca to Share Some Drug Design Data06-26-13
NCATS Eyes Changes to CTSA as Sequestration Limits Options06-25-13
Bayer, Seattle Genetics Launch Up to $520M ADC Collaboration06-25-13
Myriad to Perform BRCA Testing in CDx Deal with Tesaro06-25-13
Basilea Wins Up to $89M BARDA Contract to Develop New Antibiotic06-25-13
ADC, VivaMab Target Hematologic Cancers in Licensing Deal06-24-13
Debiopharm, Alacrita Eye More Massachusetts Deals06-24-13
Genstar Sells PRA to KKR06-24-13
Pfizer, GSK, Siemens Join Singapore's A*STAR in New Consortium06-20-13
Protalix, Brazil's Ministry of Health Ink $280M Tech Transfer Deal06-19-13
Lophius Wins $469K to Develop MS Diagnostic06-19-13
Disappointing Phase IV Cardiovascular Outcomes Results for AstraZeneca, BMS Type 2 Diabetes Drug06-19-13
T3D Licenses Drug Candidate from Dara, Repositions It for Alzheimer's06-18-13
New CHO Cell Lines on the Horizon for Hisun06-18-13
Techne Buys Bionostics for $104M06-18-13
Transition Bags $7M from Lilly for Rights to Type 2 Diabetes Candidate06-18-13
Consortium Wins $8M for Athera CV Drug PC-mAB06-17-13
Genmab, ADC Using Warheads to Make New Antibody-Drug Conjugate06-17-13
J&J Acquiring Aragon for Up To $1B06-17-13
Amgen's Denosumab Gets FDA OK for Giant-Cell Tumor Of Bone06-14-13
Lilly Halts Phase II Study of Alzheimer's Candidate06-14-13
NeuroVive, Isomerase Team Up to Study Cyclophilin Inhibitor06-13-13
Pfizer Settles Teva, Sun Patent Infringement Case for $2.15B06-13-13
Thermo Fisher, Proteome Sciences in $2.1M Technology Deal06-12-13
Aphios, VivaCell to Develop Cannabinoid-Based Drugs for MS, CNS Disorders06-12-13
Promising Phase III Results for Amgen Ovarian Cancer Candidate06-12-13
Amgen, Cytokinetics Add Japan to Heart Failure Collaboration06-12-13
NIEHS, NCATS, UNC, Others Launch Crowdsourced Toxicogenetics Challenge06-11-13
Gates Foundation, EC Agree to Fight Poverty-Related Diseases06-11-13
Questcor Acquires Synacthen Rights from Novartis in $135M+ Deal06-11-13
FDA OKs Sanofi Quadrivalent Flu Vaccine06-11-13
ExpreS2ion Licenses Protein Production Tech to Cancer Research UK06-10-13
FDA Rejects Aveo's Tivozanib for RCC; Rips Phase III Results06-10-13
Xenon Pays Isis $2M for Exclusive License to Co-Developed Antisense Drug06-10-13
Xenon Pays Isis $2M for Exclusive License to Co-Developed Antisense Drug06-10-13
Boehringer Ingelheim to Build New China Plant06-07-13
WATCH: Ph.Diddy at the Conference06-07-13
Pfizer, CytomX in Up To $635M Cancer Collaboration06-06-13
Endo Axing 700; Seeks Buyers for HealthTronics, Early-Stage Platform06-06-13
Endo Axing 700; Seeks Buyers for HealthTronics, Early-Stage Platform06-06-13
Aveo's "Sad Day": 62% of Workforce Lose Jobs06-05-13
ADA, Lilly Partner on Grant-Giving Diabetes Research Program06-05-13
Second Genome, Janssen Target Microbiome in Search for Ulcerative Colitis Drug06-05-13
Nine GSK, Stiefel Products Experience Renaissance06-04-13
Maxygen Maxes Out06-04-13
GSK Grabs MorphoSys RA Candidate in Deal Worth Up to $548M06-03-13
Phase III Failure for TeloVac Pancreatic Cancer Vaccine06-03-13
GSK Grabs MorphoSys RA Candidate in Deal Worth Up to $548M06-03-13
Onyx, UCSF Forge Cancer Innovation Alliance06-03-13
Eurofins Grows Gene Synthesis Business with Entelechon Acquisition06-03-13
Exquiron Gets New Diverse Screening Compound Library from Enamine06-03-13
Isis Wins $10M After AstraZeneca Adds Prostate Cancer Drug to Collaboration06-03-13
Onyx, UCSF Forge Cancer Innovation Alliance06-03-13
Eurofins Grows Gene Synthesis Business with Entelechon Acquisition06-03-13
Isis Wins $10M After AstraZeneca Adds Prostate Cancer Drug to Collaboration06-03-13
Exquiron Gets New Diverse Screening Compound Library from Enamine06-03-13
Axe Falls at Addex, Two Employees Remain05-31-13
Roswell Park Joins Jasco to Develop Lead Agent for Cancer05-31-13
Qiagen Picks Up New Cancer Biomarkers in Two Deals05-31-13
New Indiana Institute Targets Metabolic Disorders05-31-13
Roswell Park Joins Jasco to Develop Lead Agent for Cancer05-31-13
Qiagen Picks Up New Cancer Biomarkers in Two Deals05-31-13
New Indiana Institute Targets Metabolic Disorders05-31-13
GSK Hits Trifecta with Melanoma Drug, Dx Approvals05-30-13
Lumora Cuts Veterinary MDx Deal05-30-13
Oncothyreon Joins Array in Developing Cancer Compound05-30-13
Alethia, IBC Generium Pair Up to Develop mAB EMT Inhibitor05-29-13
GenVec Board Votes to Dissolve Company05-29-13
Amgen, Astellas Join Forces in Japan05-29-13
Virbac Buys Rights to Develop NovaBay's Auriclosene05-28-13
Cempra Wins $58M BARDA Contract05-28-13
Valeant Acquiring Bausch + Lomb for $8.7B05-28-13
HHS, GSK Hunt for Drugs to Fight Antibiotic Resistance, Bioterrorism05-22-13
FDA cGMP Complaints Draw Boehringer Ingelheim Promise of Action05-22-13
Empire Genomics Nabs Prostate Cancer Biomarker from Cornell05-22-13
Phase III Success for Boehringer Ingelheim Asthma Drug05-22-13
HHS, GSK Hunt for Drugs to Fight Antibiotic Resistance, Bioterrorism05-22-13
FDA cGMP Complaints Draw Boehringer Ingelheim Promise of Action05-22-13
Empire Genomics Nabs Prostate Cancer Biomarker from Cornell05-22-13
Phase III Success for Boehringer Ingelheim Asthma Drug05-22-13
Mayo Clinic, Cancer Genetics Form Diagnostics JV05-22-13
NIH Grant Won Toward Developing ASD, Mental Illness Gene-Seeking Software05-22-13
Grifols Taking Aradigm Stake in Up To $116M Licensing Deal05-21-13
Phase III Failure for Pfizer NHL Drug05-21-13
Novo Acquires Anti-Infective Developer Xellia for $700M05-21-13
Ignyta Snaps Up Actagene, Branches into Cancer Rx/Dx05-20-13
Collaboration Aims to Create In Vitro Human Skin05-20-13
Actavis Acquiring Warner Chilcott for $8.5B05-20-13
Collaboration Aims to Create In Vitro Human Skin05-20-13
Actavis Acquiring Warner Chilcott for $8.5B05-20-13
Amgen Forms Joint Venture to Sell Vectibix in China05-10-13
FDA OKs Novartis' Childhood Arthritis Drug05-10-13
ATMI Supplies Bioreactor for Orgenesis, Takes $1.3M Stake05-09-13
Forest Labs Bets Up To $460M on Trevena Heart Failure Drug05-09-13
Oncobiologics Finds Partner to Launch Biosimilars in U.S., China05-08-13
Booster Shot: Takeda Buys Inviragen05-08-13
AZ Giving Way to Early-Stage Biopharmas in Cheshire05-07-13
TSRI, Janssen Team Up on Infectious Disease Research05-07-13
Recipharm, Synthonics Partner to Promote Drug Delivery Tech05-07-13
Baxter Alzheimer's Drug Fails Phase III Trial05-07-13
Celgene, Concert in $300M+ Deuterium Drug Collaboration05-06-13
Sagent Assumes Control of Chinese Manufacturing JV05-06-13
Real Time Genomics, JCVI Partner to Analyze iPSCs, Validate Reference Genome Variants05-02-13
Merck Launches Up To $430M Diabetes Collaboration with Abide05-02-13
Study Shows Eritoran Can Protect Against Lethal Flu Infection05-01-13
Emergent, Caisson Collaborating to Optimize Heparosan Drug Delivery Platform05-01-13
Soligenix, Intrexon Team Up on Dual-Purpose Drug Discovery Initiative05-01-13
Parexel Acquires Heron Group in Up To $38M Deal05-01-13
Novartis, Oxford BioMedica Ink Production Agreement for Lentiviral Gene Therapy05-01-13
Ascletis Obtains Chinese Rights to Janssen HIV Treatment04-30-13
Evotec, Dana-Farber Partner on Cancer Epigenetics Drug Development04-30-13
Ligand Buys Potential Milestone/Royalty Portfolio in Up To $4.5M Deal04-30-13
Afraxis, Servier Collaborate on Drug Discovery for CNS Disorders04-30-13
NextBio, Sanofi Team Up to Incorporate Omics Data into R&D04-30-13
Qiagen Snaps Up Ingenuity for $105M04-30-13
Merck Joins Pfizer to Develop Type 2 Diabetes Drug04-29-13
GSK Parts Ways with Impax04-29-13
Celgene, Forma Team Up to Develop Protein Homeostasis Drug Candidates04-29-13
OBT Joins Boehringer Ingelheim in Cancer Drug Collaboration04-29-13
Auxilium Snaps Up Urolology Therapeutics Firm Actient in $585M Deal04-29-13
Securities Litigation Could Stall Opko-Prolor Buyout04-29-13
$20M in Financing Helps RainDance Summon ThunderStorms for Myriad04-29-13
Evotec Expands to East Coast of U.S.04-29-13
Hormone Holds Promise for Replacing Insulin Injections04-26-13
Pfizer, Alberta Renew Funding for Translational Research04-25-13
Goodwin, Coldstream Team Up to Tackle ADCs04-25-13
23andMe Survey Demonstrates ?Genetics Literacy Gap? Among Americans04-25-13
Stemedica, Kalbe Ink Stem Cell Licensing Agreement04-25-13
Novartis Cuts 300 Jobs, Names New CFO04-24-13
Agilent Takes $21M Stake in Gen904-24-13
Novartis Cuts 300 Jobs, Names New CFO04-24-13
Agilent Takes $21M Stake in Gen904-24-13
Bayer, KeyGene Partner to Improve Agricultural Crops04-24-13
Chicago Plans Biotech Commercialization Center04-24-13
Opko Health Snaps Up Prolor Biotech in $480M Deal04-24-13
Report: Orphan Drugs Cheaper to Bring to Market, Offer Better ROI04-24-13
Enzon Gives Up Hope to Sell04-24-13
Bayer, KeyGene Partner to Improve Agricultural Crops04-24-13
Chicago Plans Biotech Commercialization Center04-24-13
Opko Health Snaps Up Prolor Biotech in $480M Deal04-24-13
Report: Orphan Drugs Cheaper to Bring to Market, Offer Better ROI04-24-13
Enzon Gives Up Hope to Sell04-24-13
Enzon Ends Strategic Review, to Award Dividends04-24-13
Job Report: Better Training Essential04-23-13
Layoffs and Breakup at Roche04-23-13
Job Report: Better Training Essential04-23-13
Layoffs and Breakup at Roche04-23-13
Roche Restructures Applied Science Arm, Ends IBM Partnership to Develop Sequencing Platform04-23-13
Horizon, AstraZeneca Seek Kinase-Targeting Cancer Drugs04-22-13
AstraZeneca, BIND Enter $200M+ Cancer Nanomedicine Agreement04-22-13
FusionVax Snags Exclusive Rights to HPV Drug in Asia04-22-13
Fujifilm Builds Cell Banking and cGMP Manufacturing Facilities in the U.K.04-22-13
Tug of War Continues: Elan vs. Royalty04-22-13
Horizon, AstraZeneca Seek Kinase-Targeting Cancer Drugs04-22-13
AstraZeneca, BIND Enter $200M+ Cancer Nanomedicine Agreement04-22-13
FusionVax Snags Exclusive Rights to HPV Drug in Asia04-22-13
Fujifilm Builds Cell Banking and cGMP Manufacturing Facilities in the U.K.04-22-13
Tug of War Continues: Elan vs. Royalty04-22-13
BIO Celebrates 20th Anniversary04-22-13
EMD Serono Expanding R&D Hub in Billerica, MA04-18-13
Biosearch Moving into New Digs for GMP Production04-18-13
Illumina Partnership Eyes Expanded Presence in China04-18-13
Merck & Co. Picks Up Exclusive Option on Xenon CV Drugs04-17-13
New Single-Cell Genomic Research Center Opens in Singapore04-12-13
Life Technologies? Latest Acquisition Targets Growth Markets04-12-13
Axe Falls on 1,000 at Lilly04-12-13
BMS Grows Biologics in $250M Expansion04-11-13
Pharmacyclics Achieves Another $50M Milestone04-11-13
Yeast Strain Rises to Fight Malaria04-11-13
BHCC Receives $200,000 to Expand Biotechnology Program04-10-13
Aeterna Zentaris Sharing Costs, Profits for Cancer Drug04-10-13
Ipsen Enlists PeptiDream in Search for Therapeutic Peptides04-10-13
Inovio Wins $3.5M NIAID Grant to Advance Vaccine Device04-10-13
Shasun and Debiopharm Ink Huperzine-A Deal04-10-13
For Pregnancy Drug, a Second Birth04-09-13
GSK Sells Rights to Market Breast Cancer Drug in China04-09-13
AstraZeneca Raises S&P Eyebrows04-09-13
OriGene Snaps Up SDIX for $16M04-08-13
Ingenuity, Affymetrix Pair Products to Curb Microarray Bottlenecks04-08-13
Five Japanese Pharmas Join Drug-Development Fund04-08-13
Lego-Like Cloning Platform for Transforming Synthetic Biology04-08-13
Roche and Isis Pharmaceuticals Set Sights on Huntington's04-08-13
BMS Shores Up R&D after Trial Failure, Plavix Patent Loss04-08-13
OriGene to Acquire SDIX's Life Science Business Assets04-08-13
BRAIN Initiative Sparks Food for Thought04-05-13
KannaLife in R&D Collaboration for Cannabinoid-Based Drugs04-04-13
Furiex Wins $5 Million for Priligy Launch in France04-04-13
BRNI, Neurotrope BioScience on Search-and-Destroy Mission against Alzheimer's04-04-13
Pall Prepares to Open U.K. Life Sciences Center04-04-13
Clock Ticking in Elan Takeover Battle04-03-13
Elan Takeover Plan Faces May 10 Deadline04-03-13
Crown Takes a Second Look at Horizon04-03-13
Merck Serono Creates New Research Innovation Model04-03-13
Pfizer, BIND Launch $210M+ Targeted Nanomedicine Collaboration04-03-13
Endo Gives Up on Bioniche's Urocidin04-02-13
Analytik Jena Buys UVP, Eyes U.S. Life-Sci Presence04-02-13
Lilly Plans to Add $180 Million Insulin Manufacturing Investment04-02-13
Analytik Jena Acquires UVP, Eyes U.S. Life-Sci Presence04-02-13
Reality Hinders Pharma's Big Plans in Emerging Markets04-02-13
CDI, Coriell Win $26M Toward iPSC Lines, Biorepository04-01-13
ArQule Regains Rights to AKT Inhibitor from Daiichi Sankyo04-01-13
Dainippon Sumitomo Invests $16M in RIKEN Company03-29-13
Biopharmas Cooling to Licensing Deals as Patent Cliff Fears Ease03-29-13
Life Tech's Pleasanton, CA Facility Gets $18M MDx Makeover03-28-13
Biogen Idec Prepares to Launch 4th MS Drug03-28-13
New Joint Venture CRO Coming to Japan03-28-13
BD Expands Into Prefilled Generic Injectables03-27-13
BD Wins FDA Nod for Prefilled Generic Injectable03-27-13
Aastrom Starts Layoffs, Slashes Expenses as Phase III Trial Halted03-27-13
Myriad to Use New HRD Test with PharmaMar's DNA-Damaging Drug03-27-13
PrimeraDx on Quest for New Companion Dx03-26-13
Sixth Consecutive "Best CRO" Award Nomination for Accelovance03-26-13
Clinigen Buys Cardioxane from Novartis for $33M03-26-13
Novel Platform for Immunotherapies Created03-26-13
Lundbeck and Otsuka Enter Alzheimer's Alliance03-26-13
Novel Platform for Immunotherapy Therapies Created03-26-13
Ziopharm Restructuring After Phase III Failure03-26-13
Shire Buys SARcode Bioscience for $160M+03-25-13
Actavis Eyes 2016 Generic Crestor Launch After Settling Patent Suit with AZ03-25-13
Predictive Cancer Modeling Consortium Has New Member03-25-13
Affymetrix Genotyping 500,000 DNA Samples in UK Biobank's Next Phase03-22-13
Systems Biology Aims to Remove Animals from Contact Allergy Testing03-22-13
AstraZeneca Idling Another 2,300; Unveils Comeback Strategy03-22-13
AstraZeneca, Moderna in Up to $420M+ mRNA Drug Development Deal03-21-13
Myeloma Collaboration Unites Janssen, U.K. Institutions03-21-13
Astellas Takes On Dengue with a Little Help from Its Friends03-21-13
Valeant Portfolio Shows More Skin with $360M Obagi Deal03-20-13
Merck Sells COMT Inhibitor Rights to Cerecor03-20-13
Tackling Systemic Drug Delivery Roadblocks03-20-13
Amgen Melanoma Drug Meets Phase III Endpoint03-20-13
NPS Buys Teduglutide, PTH 1-84 Rights from Takeda for Up to $80M03-19-13
Clinical NGS Takes Step Forward03-19-13
NPS Buys Takeda's Teduglutide, PTH 1-84 Rights for Up-to-$80M03-19-13
Clinical Next-Gen Sequencing Takes Step Forward03-19-13
Pittcon Remains Analytical Product Mecca03-19-13
Blueprint Medicines Collaboration Zeroes in on Cancer Targets03-19-13
Next-Gen China Syndrome03-19-13
AstraZeneca Axing 1,600 Jobs in R&D Shuffle03-18-13
Organs-on-Chips a Step Closer to Reality03-18-13
Collbio Rescues Angel's Collagen Assets03-18-13